Prevention of recurrent herpes labialis outbreaks through low-intensity laser therapy: A clinical protocol with 3-year follow-up

Lasers in Medical Science

Volumn 27, Issue 5, 2012, Pages 1077-1083

  De Paula Eduardo, Carlos ^a   Bezinelli, Letícia Mello ^a,b   De Paula Eduardo, Fernanda ^b   Da Graça Lopes, Roberta Marques ^b   Ramalho, Karen Müller ^a   Bello Silva, Marina Stella ^a,c   Esteves Oliveira, Marcella ^d  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^c Nove de Julho University   (Brazil)

^d RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CLINICAL PROTOCOL; DIODE LASER; EPIDEMIC; FEMALE; FOLLOW UP; HERPES LABIALIS; HERPES SIMPLEX VIRUS 1; HUMAN; LOW LEVEL LASER THERAPY; PATHOGENESIS; PATIENT REFERRAL; PRIORITY JOURNAL; RECURRENT INFECTION; TREATMENT DURATION; TREATMENT OUTCOME; WOUND HEALING;

ADULT; CLINICAL PROTOCOLS; FEMALE; FOLLOW-UP STUDIES; HERPES LABIALIS; HUMANS; LASER THERAPY, LOW-LEVEL; LASERS, SEMICONDUCTOR; RECURRENCE;

EID: 84866736549     PISSN: 02688921     EISSN: 1435604X     Source Type: Journal    
DOI: 10.1007/s10103-011-1019-6     Document Type: Article

References (42)

1. Embil JA, Stephens RG, Manuel FR (1975) Prevalence of recurrent herpes labialis and aphthous ulcers among young adults on six continents. Can Med Assoc J 113(7):627-630
2. Cernik C, Gallina K, Brodell RT (2008) The treatment of herpes simplex infections: an evidence-based review. Arch Intern Med 168(11):1137-1144
3. Kolokotronis A, Doumas S (2006) Herpes simplex virus infection, with particular reference to the progression and complications of primary herpetic gingivostomatitis. Clin Microbiol Infect 12(3):202-211
4. Miller CS, Danaher RJ, Jacob RJ (1998) Molecular aspects of herpes simplex virus I latency, reactivation, and recurrence. Crit Rev Oral Biol Med 9(4):541-562
5. Harmenberg J, Oberg B, Spruance S (2010) Prevention of ulcerative lesions by episodic treatment of recurrent herpes labialis: a literature review. Acta Derm Venereol 90(2):122-130
6. Opstelten W, Neven AK, Eekhof J (2008) Treatment and prevention of herpes labialis. Can Fam Physician 54(12):1683-1687
7. Valimaa H, Waris M, Hukkanen V, Blankenvoorde MF, Nieuw Amerongen AV, Tenovuo J (2002) Salivary defense factors in herpes simplex virus infection. J Dent Res 81(6):416-421
8. Eisen D (1998) The clinical characteristics of intraoral herpes simplex virus infection in 52 immunocompetent patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 86(4):432-437
9. Higgins CR, Schofield JK, Tatnall FM, Leigh IM (1993) Natural history, management and complications of herpes labialis. J Med Virol Suppl 1:22-26
10. Spruance SL, Overall JC Jr, Kern ER, Krueger GG, Pliam V, Miller W (1977) The natural history of recurrent herpes simplex labialis: implications for antiviral therapy. N Engl J Med 297(2):69-75
11. Woo SB, Challacombe SJ (2007) Management of recurrent oral herpes simplex infections. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 103(Suppl):S12 e11-18
12. Spruance SL, Rea TL, Thoming C, Tucker R, Saltzman R, Boon R (1997) Penciclovir cream for the treatment of herpes simplex labialis. A randomized, multicenter, double-blind, placebocontrolled trial Topical Penciclovir Collaborative Study Group. JAMA 277(17):1374-1379
13. Young SK, Rowe NH, Buchanan RA (1976) A clinical study for the control of facial mucocutaneous herpes virus infections. Characterization of natural history in a professional school population. Oral Surg Oral Med Oral Pathol 41(4):498-507
14. Schubert MM, Eduardo FP, Guthrie KA, Franquin JC, Bensadoun RJ, Migliorati CA, Lloid CM, Eduardo CP, Walter NF, Marques MM, Hamdi M (2007) A phase III randomized double-blind placebo-controlled clinical trial to determine the efficacy of lowlevel laser therapy for the prevention of oral mucositis in patients undergoing hematopoietic cell transplantation. Support Care Cancer 15(10):1145-1154
15. Gilbert SC (2007) Suppressive therapy versus episodic therapy with oral valacyclovir for recurrent herpes labialis: efficacy and tolerability in an open-label, crossover study. J Drugs Dermatol 6(4):400-405
16. Baker D, Eisen D (2003) Valacyclovir for prevention of recurrent herpes labialis: 2 double-blind, placebo-controlled studies. Cutis 71(3):239-242
17. Reusser P (1996) Herpesvirus resistance to antiviral drugs: a review of the mechanisms, clinical importance and therapeutic options. J Hosp Infect 33(4):235-248
18. Strumia S, De Mitri P, Bionda E (2004) Neurotoxicity of acyclovir and valacyclovir in a hemodialyzed patient. Eur J Neurol 11(1):68-69
19. Karu T (1989) Laser biostimulation: a photobiological phenomenon. J Photochem Photobiol B 3(4):638-640
20. Lopez-Ramirez M, Vilchez-Perez MA, Gargallo-Albiol J, Arnabat-Dominguez J, Gay-Escoda C. Efficacy of low-level laser therapy in themanagement of pain, facial swelling, and postoperative trismus after a lower third molar extraction. A preliminary study Lasers Med Sci. doi:10.1007/s10103-011-0936-8
21. Safavi SM, Kazemi B, Esmaeili M, Fallah A, Modarresi A, Mir M (2008) Effects of low-level He-Ne laser irradiation on the gene expression of IL-1beta, TNF-alpha, IFN-gamma, TGF-beta, bFGF, and PDGF in rat's gingiva. Lasers Med Sci 23(3):331-335
22. Azevedo L, de Paula EF, Moreira M, de Paula EC, Marques M (2006) Influence of different power densities of LILT on cultured human fibroblast growth: a pilot study. Lasers Med Sci 21(2):86-89
23. Qadri T, Bohdanecka P, Tuner J, Miranda L, Altamash M, Gustafsson A (2007) The importance of coherence length in laser phototherapy of gingival inflammation: a pilot study. Lasers Med Sci 22(4):245-251
24. Eduardo CP, de Freitas PM, Esteves-Oliveira M, Aranha AC, Ramalho KM, Simoes A, Bello-Silva MS, Tuner J (2010) Laser phototherapy in the treatment of periodontal disease. A review. Lasers Med Sci 25(6):781-792
25. Schindl A, Neumann R (1999) Low-intensity laser therapy is an effective treatment for recurrent herpes simplex infection. Results from a randomized double-blind placebo-controlled study. J Invest Dermatol 113(2):221-223
26. Donnarumma G, De Gregorio V, Fusco A, Farina E, Baroni A, Esposito V, Contaldo M, Petruzzi M, Pannone G, Serpico R (2010) Inhibition of HSV-1 replication by laser diode-irradiation: possible mechanism of action. Int J Immunopathol Pharmacol 23(4):1167-1176
27. de Carvalho RR, de Paula EF, Ramalho KM, Antunes JL, Bezinelli LM, de Magalhaes MH, Pegoretti T, de Freitas PM, de Paula EC (2010) Effect of laser phototherapy on recurring herpes labialis prevention: an in vivo study. Lasers Med Sci 25(3):397-402
28. Bello-Silva MS, de Freitas PM, Aranha AC, Lage-Marques JL, Simoes A, de Paula EC (2010) Low-and high-intensity lasers in the treatment of herpes simplex virus 1 infection. Photomed Laser Surg 28(1):135-139
29. Marotti J, Sperandio FF, Fregnani ER, Aranha AC, de Freitas PM, Eduardo Cde P (2010) High-intensity laser and photodynamic therapy as a treatment for recurrent herpes labialis. Photomed Laser Surg 28(3):439-444
30. Marotti J, Aranha AC, Eduardo Cde P, Ribeiro MS (2009) Photodynamic therapy can be effective as a treatment for herpes simplex labialis. Photomed Laser Surg 27(2):357-363
31. Vestey JP, Norval M (1992) Mucocutaneous infections with herpes simplex virus and their management. Clin Exp Dermatol 17(4):221-237
32. Perrin D, Jolivald JR, Triki H, Garbarg-Chenon A, Lamotte D'Incamps B, Lefevre B, Malka G, Miro L, Nicolas JC (1997) Effect of laser irradiation on latency of herpes simplex virus in a mouse model. Pathol Biol (Paris) 45(1):24-27
33. Yu HS, Chang KL, Yu CL, Chen JW, Chen GS (1996) Lowenergy helium-neon laser irradiation stimulates interleukin-1 alpha and interleukin-8 release from cultured human keratinocytes. J Invest Dermatol 107(4):593-596
34. Inoue K, Nishioka J, Hukuda S (1989) Altered lymphocyte proliferation by low dosage laser irradiation. Clin Exp Rheumatol 7(5):521-523
35. Manteifel V, Bakeeva L, Karu T (1997) Ultrastructural changes in chondriome of human lymphocytes after irradiation with He-Ne laser: appearance of giant mitochondria. J Photochem Photobiol B 38(1):25-30
36. Bolton P, Young SR, Dyson M (1990) Dyson M: macrophage responsiveness to light therapy: a dose response study. Laser Therapy 2:101-106
37. Funk JO, Kruse A, Kirchner H (1992) Cytokine production after helium-neon laser irradiation in cultures of human peripheral blood mononuclear cells. J Photochem Photobiol B 16(3-4):347-355
38. Ackermann G, Hartmann M, Scherer K, Lang EW, Hohenleutner U, Landthaler M, Baumler W (2002) Correlations between light penetration into skin and the therapeutic outcome following laser therapy of port-wine stains. Lasers Med Sci 17(2):70-78
39. Tunér J, Hode L (1999) Low-level laser therapy: clinical practice and scientific background. Prima Books, Grandesberg
40. Niemz MH (1996) Laser-tissue interactions: fundamentals and applications. Springer, Berlin Heidelberg New York
41. Azevedo LH, de Paula EF, Moreira MS, de Paula EC, Marques MM (2006) Influence of different power densities of LILT on cultured human fibroblast growth: a pilot study. Lasers Med Sci 21(2):86-89
42. Karu T (1999) Primary and secondary mechanisms of action of visible to near-IR radiation on cells. J Photochem Photobiol B 49(1):1-17